Gladstone Institutional Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
49,244
-917
-2% -$214K 0.45% 49
2025
Q4
$10.4M Sell
50,161
-2,470
-5% -$488K 0.39% 53
2025
Q3
$9.76M Sell
52,631
-1,483
-3% -$254K 0.38% 55
2025
Q2
$8.27M Buy
54,114
+393
+0.7% +$60.4K 0.34% 60
2025
Q1
$8.91M Buy
53,721
+6,184
+13% +$968K 0.42% 52
2024
Q4
$6.87M Sell
47,537
-5,414
-10% -$839K 0.32% 75
2024
Q3
$8.58M Sell
52,951
-565
-1% -$90K 0.42% 58
2024
Q2
$7.82M Buy
53,516
+1,551
+3% +$231K 0.41% 58
2024
Q1
$8.22M Buy
51,965
+6,267
+14% +$998K 0.45% 46
2023
Q4
$7.16M Sell
45,698
-723
-2% -$111K 0.4% 59
2023
Q3
$7.23M Sell
46,421
-5,677
-11% -$937K 0.47% 48
2023
Q2
$8.62M Sell
52,098
-31,896
-38% -$5.15M 0.53% 37
2023
Q1
$13M Buy
83,994
+21,698
+35% +$3.5M 0.84% 18
2022
Q4
$11M Sell
62,296
-717
-1% -$124K 0.78% 18
2022
Q3
$10.3M Buy
63,013
+2,577
+4% +$436K 0.8% 22
2022
Q2
$10.7M Buy
60,436
+3,901
+7% +$695K 0.85% 19
2022
Q1
$10M Buy
56,535
+7,586
+15% +$1.29M 0.68% 26
2021
Q4
$8.37M Buy
48,949
+9,488
+24% +$1.55M 0.65% 32
2021
Q3
$6.37M Buy
39,461
+9,558
+32% +$1.63M 0.62% 38
2021
Q2
$4.93M Buy
29,903
+15,426
+107% +$2.55M 0.59% 39
2021
Q1
$2.38M Buy
14,477
+3,828
+36% +$619K 0.37% 68
2020
Q4
$1.68M Buy
10,649
+2,494
+31% +$368K 0.33% 70
2020
Q3
$1.21M Buy
8,155
+176
+2% +$26K 0.29% 77
2020
Q2
$1.12M Sell
7,979
-2,600
-25% -$379K 0.29% 77
2020
Q1
$1.39M Buy
10,579
+2,625
+33% +$372K 0.36% 64
2019
Q4
$1.16M Sell
7,954
-90
-1% -$12.2K 0.28% 73
2019
Q3
$1.04M Buy
8,044
+1,707
+27% +$225K 0.26% 76
2019
Q2
$883K Buy
6,337
+3,215
+103% +$445K 0.27% 82
2019
Q1
$437K Sell
3,122
-569
-15% -$76.2K 0.16% 119
2018
Q4
$476K Buy
+3,691
New +$515K 0.28% 84

Other funds holding JNJ

Gladstone Institutional Advisory's JNJ Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $214K and leaving 49,244 shares worth $12M. The position accounts for 0.45% of the portfolio, ranked #49.

Gladstone Institutional Advisory first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $13M in Q1 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gladstone Institutional Advisory held 49,244 shares of Johnson & Johnson worth $12M as of Q1 2026.
  • Gladstone Institutional Advisory sold 917 Johnson & Johnson shares in Q1 2026, an estimated $214K.
  • Johnson & Johnson made up 0.45% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #49 holding.
  • Gladstone Institutional Advisory first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • Gladstone Institutional Advisory's Johnson & Johnson position peaked at $13M in Q1 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.